Regenerex Pharma (RGPX) Times Interest Earned (2013 - 2025)

Regenerex Pharma (RGPX) has 9 years of Times Interest Earned data on file, last reported at -$196.68 in Q3 2025.

• Times Interest Earned for Q3 2025 came in at -$196.68, down 20159.39% year-over-year; the trailing twelve-month figure through Sep 2025 was -$7.63 (down 185.95% YoY), and the FY2025 annual result was -$5.71, up 86.72% from the prior year.
• Times Interest Earned fell to -$196.68 in Q3 2025 per RGPX's latest filing, from -$26.86 in the prior quarter.
• Over five years, Times Interest Earned peaked at -$0.43 in Q1 2023 and troughed at -$196.68 in Q3 2025.
• A 5-year average of -$23.81 and a median of -$3.44 in 2024 frame the typical range for Times Interest Earned.
• The sharpest annual moves came in 2024 and 2025: Times Interest Earned soared 99.31% in 2024, then tumbled 20159.39% in 2025.
• A 5-year view of Times Interest Earned shows it stood at -$4.26 in 2021, then jumped by 60.38% to -$1.69 in 2022, then plunged by 601.42% to -$11.84 in 2023, then increased by 2.61% to -$11.53 in 2024, then sank by 1605.7% to -$196.68 in 2025.
• Business Quant data shows RGPX's Times Interest Earned at -$196.68 in Q3 2025, -$26.86 in Q2 2025, and -$3.3 in Q1 2025.